1Martin RC, Derossi AM, Fey J, et al. Intradermal isotope injection is surperior to intramammary in sentinel node biopsy for breast cancer. Surgery,2001,130(3) :432 - 438
2McMasters KM, Gioliano AE, Ross MI, et al.Sentinel-lymph-node biopsy for breast cancer--not yet the standard of care. N Engl J Med, 1998,339(14) :990 - 995
3Noguchi M. Sentinel lymph node biopsy and breast cancer. Br J Surg,2002,89(1 ) :21 - 34
4Ahrendt GM, Laud P, Tjoe J, et al. Does breast tumor location influence success of sentinel lymph node biopsy. J Am Coil Surg,2002,194(3) :278 - 284
5Weaver DL. Sentinel lymph nodes and breast carcinoma:which micrometastases are clinically significiant. Am J Surg Pathol, 2003, 27(6): 842 - 845
6Sachdev U, Murphy K, Derzie A, et al. Predictors of nonsentinel lymph node metastasis in breast cancer patinents. A J Surg, 2002,183(2):213- 217
1Solorzano CC, Ross MI, Delpassnd E, et al. Utility of breast sentinel lymph node biopsy using day-before-surgery injection of high-dose ^99Tc^m-sulfur colloid. Ann Sturg Oncol, 2001, 8: 821-827.
2McCarter MD, Yeung H, Yeh S, et al. Localization of the sentinel node in breast cancer: identical results with same-day and day-before isotope injection. Ann Stag Oncol, 2001, 8 : 682-686.
3Bauer TW, Spitz FR, Callans LS, et al. Subareolar and peritumoral injection identify similar sentinel nodes for breast cancer. Ann Stag Oncol,2002, 9: 169-176.
4Shimazu K, Tamaki Y, Taguchi T, et al. Comparison between periareolar and peritumoral injection of radiotracer for sentinel lymph node biopsy in patients with breast cancer. Surgery, 2002, 131: 277-286.
1Weaver D L, Ashikaga T, Harlovo S P, et al. Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma [J]. Cancer, 2000,88(5) : 1099-1107.
2Nason K S, Anderson B O, Donohue J H, et al. Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma [J ]. Cancer, 2000,89 ( 1 ) :2187-2194.
3McMasters K M, Giuliano A E, Ross M I, et al. Sentinellymph-node biopsy for breast cancer-not yet the standard of care [J]. N Engl J Med, 1998,339(14):990-995.
4Turner R R, Olilla D W, Krasne D L, et al. Histopathologic validation of the breast sentinel lymph node hypothesis for carcinoma [J]. Ann Surg, 1997,226(3):217-218.
5Mann B G, Buchana M, Collins P J, et al. High incidence of micrometastases in breast cancer sentinel nodes [J]. Aust N Z J Surg, 2000,70( 11 ) : 786-790.
6Liu L H, Siziopikou K P, Gabram S, et al. Evaluation of axillary sentinel lymph node biopsy by immunohistochemistry and multilevel section in patients with breast cancer [J ]. Arch Pathol Lab Med, 2000,124( 11 ) : 1670-1673.
7Creager A J, Geisinger K R. Intraoperative evaluation of sentinel lymph nodes for breast carcinoma: current methodologies [J]. Adv Anat Pathol, 2002,9 (4) : 233-243.
8Nahrig J M, Richter T, Kuhn W, et al. Intraoperative examination of sentinel lymph nodes by ultrarapid immunohistochemistry [ J ]. Breast J, 2003,9 (4) : 277-281.
9Roumen R M, Kuijt G P, Liem I H, et al. Treatment of 100 patients with sentinel node-negative breast cancer without further axillary dissection [J]. Br J Surg, 2001,88(12) : 1639-1643.
10Lyman G, Giuliano A E, Somerfield M R, et al. American Society of Clinical Oneology guiodeline recommendations for sentinel lymph node biopsy in early-stage breast cancer [J]. J Clin Oneol, 2005,23 (30) : 7703-7720.
